Exhibit 99.1
Joint Filing Agreement
The undersigned hereby agree that the Statement on Schedule 13G dated January 27, 2023 with respect to the Common Stock, par value $0.0001 per share, of Jasper Therapeutics, Inc., and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Dated: January 27, 2023
Velan Capital Partners LP | |||
By: | Velan Capital Holdings LLC General Partner | ||
By: | /s/ Adam Morgan | ||
Name: | Adam Morgan | ||
Title: | Managing Member |
Avego Healthcare Capital, L.P. | |||
By: | Avego Healthcare Capital Holdings, LLC General Partner | ||
By: | /s/ Balaji Venkataraman | ||
Name: | Balaji Venkataraman | ||
Title: | Managing Member |
Velan Capital Holdings LLC | |||
By: | /s/ Adam Morgan | ||
Name: | Adam Morgan | ||
Title: | Managing Member |
Avego Healthcare Capital Holdings, LLC | |||
By: | /s/ Balaji Venkataraman | ||
Name: | Balaji Venkataraman | ||
Title: | Managing Member |
Avego Management, LLC | |||
By: | /s/ Balaji Venkataraman | ||
Name: | Balaji Venkataraman | ||
Title: | Managing Member |
Velan Capital Investment Management LP | |||
By: | Velan Capital Holdings LLC General Partner | ||
By: | /s/ Adam Morgan | ||
Name: | Adam Morgan | ||
Title: | Managing Member |
Velan Capital Management, LLC | |||
By: | /s/ Adam Morgan | ||
Name: | Adam Morgan | ||
Title: | Managing Member |
/s/ Balaji Venkataraman | |
Balaji Venkataraman |
/s/ Adam Morgan | |
Adam Morgan |